Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biosensor Technology To Monitor Aging Processes Needed – NIH

This article was originally published in The Gray Sheet

Executive Summary

The National Institute on Aging hopes to fund the development of non-invasive biosensor monitors to track the aging process, according to NIA Geriatrics Health Program Specialist Winifred Rossi

You may also be interested in...



Medtronic Artificial Pancreas Sustains Normal Glucose 42% Of The Time

Medtronic/MiniMed continues to predict that its artificial pancreas technology will reach the U.S. market in five years, based on early-stage data showing the system maintains glucose levels in the near-normal range 42% of the time

Cygnus GlucoWatch Biographer Non-Invasive Glucose Monitor Lists For $595

Cygnus' full-scale U.S. launch of the GlucoWatch Biographer non-invasive glucose monitoring system April 15 includes a direct mail list price of $595

Diagnostics Development Highlighted In NIH Bioterrorism Agenda

Microchip array-based platforms that include large numbers of microbial signatures should be pursued in the development of new diagnostics for bioterrorist threats, according to the National Institutes of Allergy and Infectious Diseases' most recent bioterrorism research agenda

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel